Trial
NCT00958074
Vorinostat in Patients With Primary Cutaneous T-Cell Lymphoma
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Washington
Collaborators
National Cancer Institute (NCI)
Condition
Cutaneous T-cell Lymphoma Stage I
Intervention
vorinostat
Why stopped
Terminated due to slow accrual
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-10-18